Ocrelizumab, which is sometimes called an Ocrevus injection, is an intravenous injection used to treat various types of multiple sclerosis, such as clinically isolated syndrome, active secondary progressive disease, relapsing-remitting MS (RRMS), and primary progressive multiple sclerosis (PPMS)
Targeting the myostatin signaling pathway to treat muscle loss and metabolic dysfunction
Avoid Toxins Reducing exposure to environmental toxins, such as pesticides, heavy metals, and pollutants, can help mitigate inflammation and oxidative stress in the gut
Previously, John served as Chief Investment Officer at ASB Capital Management, where he was responsible for the management of fixed-income assets totaling over $1 billion
The STEP trial extension data covers up to 2 years, showing maintained weight loss as long as treatment continues